Inside Duke Medicine
Media Spotlight: WRAL highlights prostate cancer vaccine made from patient’s white blood cells
posted March 18th, 2010
This story reports on a Duke clinical trial that uses a prostate cancer patient’s white blood cells to produce a vaccine.
“It's the patient's own immune cells which are taught essentially to, in the broad sense, taught to recognize prostate cancer cells,” said, Deborah Bradley, M.D, assistant professor of medicine.